Table 1.
Study | Technique | Patients/ nodes | Sensitivity (%) | Specificity (%) | Negative predictive value (%) | Comment |
---|---|---|---|---|---|---|
Horowitz et al.[33] | PET | Patients: 19 | 67 | 94 | In patients with moderate or high-grade histology | |
Nodes | 60 | 98 | ||||
Suzuki et al.[34] | PET | Patients: 30 | Did not identify any metastatic node that was < 10 mm in diameter | |||
Kitajima et al.[35] | PET/CT | Patients: 40 | 50 | 86.7 | ||
Nodes: 1484 | 53 | 99.6 | ||||
Nayot et al.[36] | PET/CT | Patients: 12 | ||||
Nodes | 53 | 99 | ||||
Park et al.[74] | PET/CT | Patients: 53 | No difference when compared with MRI (P = 0.25 (sensitivity)) | |||
Nodal site | 69.2 | 90 | ||||
Picchio et al.[37] | PET/CT | Patients: 32 | 57 | 100 | 86 | In patients with high-grade histology; 5 cases of additionally detected extranodal metastatic disease |
Nodes: not available | ||||||
Signorelli et al.[38] | PET/CT | Patients: 37 | 77.8 | 100 | 93.3 | 11 patients with grade 2/deep invasion and 26 patients with grade 3 histology |
Nodal site | 66.7 | 99.4 | 97.2 |